| Product Code: ETC7631644 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Hereditary Angioedema Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Hereditary Angioedema Market - Industry Life Cycle |
3.4 Ireland Hereditary Angioedema Market - Porter's Five Forces |
3.5 Ireland Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of hereditary angioedema in Ireland |
4.2.2 Advancements in treatment options and therapies for hereditary angioedema |
4.2.3 Growing research and development activities focused on hereditary angioedema |
4.3 Market Restraints |
4.3.1 High cost associated with hereditary angioedema treatments |
4.3.2 Limited availability of specialized healthcare professionals for hereditary angioedema management |
4.3.3 Regulatory challenges related to the approval and access to new therapies for hereditary angioedema |
5 Ireland Hereditary Angioedema Market Trends |
6 Ireland Hereditary Angioedema Market, By Types |
6.1 Ireland Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Ireland Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Ireland Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Ireland Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Ireland Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Ireland Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Ireland Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Ireland Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Ireland Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Ireland Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Ireland Hereditary Angioedema Market Export to Major Countries |
7.2 Ireland Hereditary Angioedema Market Imports from Major Countries |
8 Ireland Hereditary Angioedema Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed hereditary angioedema treatment plans |
8.2 Number of clinical trials conducted for new hereditary angioedema therapies in Ireland |
8.3 Rate of hospital admissions due to hereditary angioedema exacerbations |
9 Ireland Hereditary Angioedema Market - Opportunity Assessment |
9.1 Ireland Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Hereditary Angioedema Market - Competitive Landscape |
10.1 Ireland Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Ireland Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here